GAP:NYSEGap, Inc. (The) Analysis
Data as of 2026-06-13 - not real-time
$21.89
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Gap’s stock trades at $21.89, well below its 20‑day SMA of 21.97 and the 200‑day SMA of 24.58, indicating a bearish technical backdrop, while the RSI of 46.8 suggests neutral momentum. The MACD histogram has turned positive (0.07), offering a modest bullish signal, but volume is on a decreasing trend, reinforcing short‑term pressure. Support sits at $20.05 and resistance at $25.32, giving the price a limited upside corridor in the near term. Fundamentally, the company boasts a low forward PE of 8.7, a dividend yield of 3.2% with a modest payout ratio of 26%, and a DCF fair value of $27.10, implying roughly a 25% upside potential. Recent earnings surprised to the upside, with GAAP EPS of $0.90 beating consensus by 87.6%, and operating margins remain healthy at 12.7%. However, revenue growth is flat at 1% year‑over‑year, and the sector’s consumer‑cyclical nature adds sensitivity to discretionary spending trends.
The stock’s beta of around 1.36 and 30‑day volatility above 65% point to heightened market risk, while the decreasing volume trend raises liquidity concerns. Gap’s balance sheet shows a debt‑to‑equity ratio exceeding 150%, though cash generation and free cash flow remain positive, supporting dividend sustainability. Analyst consensus leans “Buy” with a mean target price near $27.5, aligning with the valuation gap. Overall, the fundamentals suggest undervaluation and dividend appeal, but technical weakness and elevated risk temper short‑term optimism.
The stock’s beta of around 1.36 and 30‑day volatility above 65% point to heightened market risk, while the decreasing volume trend raises liquidity concerns. Gap’s balance sheet shows a debt‑to‑equity ratio exceeding 150%, though cash generation and free cash flow remain positive, supporting dividend sustainability. Analyst consensus leans “Buy” with a mean target price near $27.5, aligning with the valuation gap. Overall, the fundamentals suggest undervaluation and dividend appeal, but technical weakness and elevated risk temper short‑term optimism.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish technical positioning relative to moving averages
- Decreasing trading volume
- Price hovering just above key support
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued valuation metrics (low PE, DCF upside)
- Strong dividend yield with low payout ratio
- Earnings beat and solid operating margins
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Sustainable dividend supported by cash flow
- Robust ROE and ROA for a consumer retailer
- Potential turnaround in revenue growth and brand repositioning
Key Metrics & Analysis
Financial Health
Revenue Growth1.00%
Profit Margin6.25%
P/E Ratio8.7
ROE27.58%
ROA6.79%
Debt/Equity154.36
P/B Ratio2.2
Op. Cash Flow$1.6B
Free Cash Flow$928.5M
Technical Analysis
TrendBearish
RSI46.8
Support$20.05
Resistance$25.32
MA 20$21.97
MA 50$23.58
MA 200$24.58
MACDBullish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
Fair Value$27.10
Target Price$27.55
Upside/Downside25.87%
GradeUndervalued
TypeValue
Dividend Yield3.20%
Risk Assessment
Beta1.36
Volatility65.84%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.